Bayesian Assessment of Sample Size for Clinical Trials of Cost-Effectiveness

The authors present an analysis of the choice of sample sizes for demonstrating cost-effectiveness of a new treatment or procedure, when data on both cost and efficacy will be collected in a clinical trial. The Bayesian approach to statistics is employed, as well as a novel Bayesian criterion that provides insight into the sample size problem and offers a very flexible formulation.

[1]  J C Gardiner,et al.  Power and sample assessments for tests of hypotheses on cost-effectiveness ratios. , 2000, Health economics.

[2]  A R Willan,et al.  Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. , 1999, Health economics.

[3]  M. Kendall,et al.  Kendall's advanced theory of statistics , 1995 .

[4]  Marvin Zelen,et al.  Clinical Trials and Sample Size Considerations: Another Perspective , 2000 .

[5]  M Meisner,et al.  Statistical inference for cost-effectiveness ratios. , 1997, Health economics.

[6]  A. W. Kemp,et al.  Kendall's Advanced Theory of Statistics. , 1994 .

[7]  K. Chaloner,et al.  Bayesian Experimental Design: A Review , 1995 .

[8]  D. Lindley.  The choice of sample size , 1997 .

[9]  A H Briggs,et al.  Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  Morris Meisner,et al.  Power and Sample Size in Cost- Effectiveness Analysis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  Second edition of the guidelines for economic evaluation of pharmaceuticals , 1998 .

[13]  Allen S. Mandel.  Comment … , 1978, British heart journal.

[14]  D. Spiegelhalter,et al.  A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. , 1986, Statistics in medicine.

[15]  P. Wakker,et al.  Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.

[16]  Joseph B. Kadane,et al.  Optimal Experimental Design for Another's Analysis , 1993 .

[17]  C. J. Adcock,et al.  The choice of sample size. Commentaries. Author's reply , 1997 .

[18]  Andrew Briggs,et al.  The Design and Analysis of Stochastic Cost-Effectiveness Studies for the Evaluation of Health Care Interventions , 2001 .

[19]  A O'Hagan,et al.  A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.

[20]  Nozer D. Singpurwalla,et al.  On the Evidence Needed to Reach Agreed Action between Adversaries, with Application to Acceptance Sampling , 1991 .

[21]  J. Hutton,et al.  Bayesian sample size calculations and prior beliefs about child , 1993 .

[22]  A R Willan,et al.  Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.

[23]  D Menon,et al.  Canadian Coordinating Office for Health Technology Assessment. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  Assessment of Treatment with Lisinopril and Survival ATLAS study. , 1999, International journal of clinical practice. Supplement.

[25]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.